Syndax Pharmaceuticals Inc. is a biotechnology company located in New York, New York. Situated at 730 3rd Avenue, Suite 900, this company focuses on advancing the development of innovative therapies through biotechnological research and development. Syndax Pharmaceuticals is known for its dedication to exploring novel approaches in the pharmaceutical sector, particularly in the realm of oncology and immunotherapy. The company leverages cutting-edge scientific methods to create treatment options aimed at addressing unmet medical needs.
Operating within the competitive biotechnology industry, Syndax Pharmaceuticals Inc. emphasizes a research-driven approach to drug development. Its team of scientists and researchers work collaboratively to identify promising molecular targets and develop compounds that may improve patient outcomes. The organization’s activities encompass a broad spectrum of biotechnology processes, including preclinical studies and clinical trial design, which are essential components of bringing new pharmaceutical products to market.
Located in the heart of New York City, Syndax Pharmaceuticals benefits from access to a robust network of medical institutions, research centers, and industry partners. This strategic location supports ongoing collaborations and facilitates the exchange of scientific knowledge. By maintaining a focus on innovation and scientific rigor, the company contributes to the advancement of medical science within the biotechnology sector.
Syndax Pharmaceuticals Inc. can be contacted by phone at 781-419-1400 for inquiries related to its biotechnology services and ongoing projects. The company continues to play a role in the evolving landscape of pharmaceutical research, with an emphasis on developing therapies that have the potential to impact patient care positively.
